Products

Veloxis Pharmaceuticals (Veloxis) is a speciality pharmaceutical company focused on the development of LCP-Tacro for the prevention of organ rejection in kidney transplant patients.

As Veloxis is focussing its efforts and resources on the development, regulatory approval and commercialisation of LCP-Tacro, the company is discontinuing future efforts to identify partners for its existing pipeline cardiovascular assets.